Ingevity Corp (NASDAQ:NGVT) – Research analysts at SunTrust Banks increased their Q3 2017 EPS estimates for Ingevity Corp in a note issued to investors on Friday. SunTrust Banks analyst J. Sheehan now anticipates that the company will earn $0.72 per share for the quarter, up from their prior forecast of $0.69. SunTrust Banks also issued estimates for Ingevity Corp’s Q4 2017 earnings at $0.34 EPS, FY2017 earnings at $2.34 EPS, FY2018 earnings at $2.50 EPS and FY2019 earnings at $3.14 EPS.

Ingevity Corp (NASDAQ:NGVT) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $0.78 EPS for the quarter, beating the consensus estimate of $0.70 by $0.08. Ingevity Corp had a net margin of 10.53% and a return on equity of 55.06%. The business had revenue of $260.30 million during the quarter, compared to analyst estimates of $259.56 million. The company’s quarterly revenue was up 2.3% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: “SunTrust Banks Weighs in on Ingevity Corp’s Q3 2017 Earnings (NGVT)” was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/08/07/suntrust-banks-weighs-in-on-ingevity-corps-q3-2017-earnings-ngvt.html.

NGVT has been the topic of several other reports. Zacks Investment Research lowered shares of Ingevity Corp from a “hold” rating to a “sell” rating in a research report on Wednesday, April 26th. Jefferies Group LLC set a $68.00 target price on shares of Ingevity Corp and gave the stock a “buy” rating in a research report on Wednesday, July 5th. Finally, Aegis restated a “buy” rating and set a $67.00 target price on shares of Ingevity Corp in a research report on Tuesday, July 4th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. Ingevity Corp has a consensus rating of “Hold” and an average target price of $64.75.

Ingevity Corp (NGVT) opened at 61.40 on Monday. The company has a market cap of $2.58 billion and a price-to-earnings ratio of 49.04. Ingevity Corp has a 1-year low of $37.53 and a 1-year high of $65.02. The company’s 50 day moving average is $57.17 and its 200 day moving average is $57.98.

Large investors have recently added to or reduced their stakes in the company. Federated Investors Inc. PA raised its stake in Ingevity Corp by 31.7% in the second quarter. Federated Investors Inc. PA now owns 586,600 shares of the company’s stock valued at $33,671,000 after buying an additional 141,100 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in Ingevity Corp by 13.8% in the second quarter. State Board of Administration of Florida Retirement System now owns 30,932 shares of the company’s stock valued at $1,775,000 after buying an additional 3,762 shares in the last quarter. Marshall Wace North America L.P. raised its stake in Ingevity Corp by 4,456.0% in the second quarter. Marshall Wace North America L.P. now owns 263,974 shares of the company’s stock valued at $15,046,000 after buying an additional 258,180 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in Ingevity Corp by 454.4% in the second quarter. BNP Paribas Arbitrage SA now owns 49,555 shares of the company’s stock valued at $2,844,000 after buying an additional 40,617 shares in the last quarter. Finally, Legal & General Group Plc raised its stake in Ingevity Corp by 8.0% in the second quarter. Legal & General Group Plc now owns 81,181 shares of the company’s stock valued at $4,654,000 after buying an additional 6,020 shares in the last quarter.

In other Ingevity Corp news, Director Jean S. Blackwell acquired 1,500 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were acquired at an average cost of $58.38 per share, for a total transaction of $87,570.00. Following the transaction, the director now directly owns 4,711 shares of the company’s stock, valued at $275,028.18. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Ingevity Corp Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Earnings History and Estimates for Ingevity Corp (NASDAQ:NGVT)

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.